“Stability Indicating RP-UPLC Method Development & Validation for Quantitation of Doravirine in Tablet Formulation ” (2023) Journal of Pharmaceutical Negative Results, 13(4), pp. 1776–1782. doi:10.47750/pnr.2022.13.04.243.